Failure of two retinoids to inhibit tracheal carcinogenesis in hamsters

Authors:
  • PNPaul Nettesheim
    Paul Nettesheim
  • TMToby J. Mitchell
    Toby J. Mitchell

Abstract
The effect of 2 retinoids, 13-cis-retinoic acid and 4-methoxy-2,3,6-trimethylphenyl analog of retinoic acid ethyl amide (Roll-1430), on tracheal tumor development in hamsters exposed to N-nitroso-N-methylurea was tested. Hamsters were intratracheally exposed 18, 20 or 23 times to 1% N-nitroso-N-methylurea before the retinoids were administered in the diet. Evidence was presented which indicates that the great majority of the animals are free of invasive neoplasia at the start of retinoid feeding. In none of the 6 retinoid-treated groups could a statistically significant inhibition of tumor development be demonstrated. Hamsters treated with 13-cis-retinoic acid (128 or 172 mg/kg of diet) tended to have an elevated cancer risk; this effect was at a statistically significant level in the group treated with 172 mg/kg of diet. The distribution of histologic tumor types seemed to be shifted in favor of adeno- and mixed adeno-epidermoid tumors in the group receiving a low carcinogen dose and Roll-1430. 13-cis-Retinoic acid and the retinoic acid ethyl amide analog Roll-1430 failed to inhibit development of respiratory tract neoplasms. The reason for this may be the absence of significant promoting influences in the current lung cancer models and that retinoids act mostly as antipromoters.